Listed

Health In Tech, Inc.

HITNasdaqCIK 2019505FinancialsFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$8.1mRevenue, Q2 FY2026, three months to 2026-06-30$8.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089157.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 13, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$8.1mRevenue, Q2 FY2026, three months to 2026-06-30$8.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089157.Report this figure−13.5% on a year earlier
  • Gross margin48.7%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $3.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001213900-26-089157.Revenue: $8.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089157.Report this figure−19.1 pts on a year earlier
  • Operating marginnot reported (Operating income not reported)No year-earlier figure to compare
  • Net margin−31.2%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089157.Revenue: $8.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089157.Report this figure−37.9 pts on a year earlier
  • Diluted EPS−$0.04Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001213900-26-089157.Report this figureSign changed from a year earlier
  • Free cash flownot reported (Capital expenditure not reported)No year-earlier figure to compare

Last eight quarters

Full statements
Revenue$8.1mGross margin 48.7%
Diluted EPS−$0.04, Q2 FY2026
Health In Tech, Inc., key figures for the last eight quarters
Line itemUnitperiod not labelled2024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$k4,459Revenue, period not labelled, three months to 2024-09-30$4.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-12, accession 0001213900-25-109379.Report this figure4,905Revenue, Q4 FY2024, three months to 2024-12-31$4.9m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-25, accession 0001213900-26-034211. Derived: 12-month figure less the 9-month figure.Report this figure8,015Revenue, Q1 FY2025, three months to 2025-03-31$8.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001213900-26-056707.Report this figure9,314Revenue, Q2 FY2025, three months to 2025-06-30$9.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089157.Report this figure8,490Revenue, Q3 FY2025, three months to 2025-09-30$8.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-12, accession 0001213900-25-109379.Report this figure7,509Revenue, Q4 FY2025, three months to 2025-12-31$7.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-25, accession 0001213900-26-034211. Derived: 12-month figure less the 9-month figure.Report this figure8,772Revenue, Q1 FY2026, three months to 2026-03-31$8.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001213900-26-056707.Report this figure8,057Revenue, Q2 FY2026, three months to 2026-06-30$8.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089157.Report this figure
Gross margin%78.0%Gross margin, period not labelled, three months to 2024-09-30. gross profit / revenueGross profit: $3.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-12, accession 0001213900-25-109379.Revenue: $4.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-12, accession 0001213900-25-109379.Report this figure77.4%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $3.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-25, accession 0001213900-26-034211. Derived: 12-month figure less the 9-month figure.Revenue: $4.9m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-25, accession 0001213900-26-034211. Derived: 12-month figure less the 9-month figure.Report this figure66.8%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $5.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-14, accession 0001213900-26-056707.Revenue: $8.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001213900-26-056707.Report this figure67.7%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $6.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001213900-26-089157.Revenue: $9.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089157.Report this figure60.6%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $5.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-12, accession 0001213900-25-109379.Revenue: $8.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-12, accession 0001213900-25-109379.Report this figure55.0%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $4.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-25, accession 0001213900-26-034211. Derived: 12-month figure less the 9-month figure.Revenue: $7.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-25, accession 0001213900-26-034211. Derived: 12-month figure less the 9-month figure.Report this figure51.4%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $4.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-14, accession 0001213900-26-056707.Revenue: $8.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001213900-26-056707.Report this figure48.7%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $3.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001213900-26-089157.Revenue: $8.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089157.Report this figure
Operating margin%not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)
Net margin%8.4%Net margin, period not labelled, three months to 2024-09-30. net income / revenueNet income: $376.1k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001213900-25-109379.Revenue: $4.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-12, accession 0001213900-25-109379.Report this figure(2.9%)Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: −$144.2k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001213900-26-034211. Derived: 12-month figure less the 9-month figure.Revenue: $4.9m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-25, accession 0001213900-26-034211. Derived: 12-month figure less the 9-month figure.Report this figure6.2%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $498.6k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001213900-26-056707.Revenue: $8.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001213900-26-056707.Report this figure6.8%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $630.6k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089157.Revenue: $9.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089157.Report this figure5.3%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $452.2k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001213900-25-109379.Revenue: $8.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-12, accession 0001213900-25-109379.Report this figure(4.0%)Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: −$302.6k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001213900-26-034211. Derived: 12-month figure less the 9-month figure.Revenue: $7.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-25, accession 0001213900-26-034211. Derived: 12-month figure less the 9-month figure.Report this figure(18.1%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001213900-26-056707.Revenue: $8.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001213900-26-056707.Report this figure(31.2%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089157.Revenue: $8.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089157.Report this figure
Diluted EPS$ per share0.01Diluted EPS, period not labelled, three months to 2024-09-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001213900-25-109379.Report this figurenot reported (Diluted EPS not reported)0.01Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001213900-26-056707.Report this figure0.01Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001213900-26-089157.Report this figure0.01Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001213900-25-109379.Report this figurenot reported (Diluted EPS not reported)(0.03)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001213900-26-056707.Report this figure(0.04)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001213900-26-089157.Report this figure
Free cash flow$knot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$33.3mGross margin 62.8%
Diluted EPS$0.02, FY2025
Health In Tech, Inc., key figures for the last five fiscal years
Line itemUnitFY2023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m19.2Revenue, period not labelled, twelve months to 2023-12-31$19.2m. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-17, accession 0001213900-25-024561.Report this figure19.5Revenue, FY2024, twelve months to 2024-12-31$19.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-25, accession 0001213900-26-034211.Report this figure33.3Revenue, FY2025, twelve months to 2025-12-31$33.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-25, accession 0001213900-26-034211.Report this figure
Gross margin%88.0%Gross margin, period not labelled, twelve months to 2023-12-31. gross profit / revenueGross profit: $16.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-17, accession 0001213900-25-024561.Revenue: $19.2m. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-17, accession 0001213900-25-024561.Report this figure79.2%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $15.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-25, accession 0001213900-26-034211.Revenue: $19.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-25, accession 0001213900-26-034211.Report this figure62.8%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $20.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-25, accession 0001213900-26-034211.Revenue: $33.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-25, accession 0001213900-26-034211.Report this figure
Operating margin%not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)
Net margin%20.7%Net margin, period not labelled, twelve months to 2023-12-31. net income / revenueNet income: $4.0m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2025-03-17, accession 0001213900-25-024561.Revenue: $19.2m. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-17, accession 0001213900-25-024561.Report this figure3.4%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $670.5k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001213900-26-034211.Revenue: $19.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-25, accession 0001213900-26-034211.Report this figure3.8%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001213900-26-034211.Revenue: $33.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-25, accession 0001213900-26-034211.Report this figure
Diluted EPS$ per sharenot reported (Diluted EPS not reported)0.01Diluted EPS, FY2024, twelve months to 2024-12-31$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-25, accession 0001213900-26-034211.Report this figure0.02Diluted EPS, FY2025, twelve months to 2025-12-31$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-25, accession 0001213900-26-034211.Report this figure
Free cash flow$mnot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Health In Tech, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
Whetstone Capital Advisors, LLC2026-06-30$1.5m1,509,766New+1,509,766
Mink Brook Asset Management LLC2026-06-30$1.1m1,133,369Added+326,908
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$574.2k568,475Added+3,000
HEIGHTS CAPITAL MANAGEMENT, INC2026-06-30$353.8k350,268Reduced−23,030
BlackRock, Inc.2026-06-30$353.1k349,595Added+64,940
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$222.9k220,650Added+37,325
CITADEL ADVISORS LLC2026-06-30$178.7k176,911Added+140,279
VANGUARD FIDUCIARY TRUST CO2026-06-30$131.8k130,482Added+55,914
STATE STREET CORP2026-06-30$63.5k62,900Unchanged
NORTHERN TRUST CORP2026-06-30$58.2k57,659Added+21,509

Recent filings

All 176 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Health In Tech, Inc., recent filings
FiledFormWhat it isAccession number
2026-10-2616:33 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-26-112502
2026-10-1616:30 ET8-K3.01 Delisting notice0001213900-26-110269
2026-10-1308:00 ETDEF 14AProxy statementPeriod 2026-11-100001213900-26-108738
2026-09-3016:35 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-26-105280
2026-08-1317:17 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-26-089249
2026-08-1316:35 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-26-089165
2026-08-1316:35 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-26-089164
2026-08-1316:31 ET10-QQuarterly reportPeriod 2026-06-300001213900-26-089157
2026-05-1416:34 ET10-QQuarterly reportPeriod 2026-03-310001213900-26-056707
2026-05-1418:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-26-056014

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 25, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
2019505
Tickers
HIT
Exchange
Nasdaq
SIC code
6411 Insurance Agents, Brokers & Service
Sector
Financials
Fiscal year ends
Dec 31
Incorporated in
not reported
Filer category
<br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 04:33 ET. Listed shows no prices and gives no investment advice.